Evidence map›Paper›PMID 29949961›Full record

ArticleBioinformatics (Oxford, England)2018

DisruPPI: structure-based computational redesign algorithm for protein binding disruption.

Yoonjoo Choi, Jacob M Furlon, Ryan B Amos, Karl E Griswold, Chris Bailey-Kellogg

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yoonjoo ChoiDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
Jacob M FurlonThayer School of Engineering, Dartmouth, Hanover, NH, USA.
Ryan B AmosDepartment of Computer Science, Princeton University, Princeton, NJ, USA.
Karl E GriswoldThayer School of Engineering, Dartmouth, Hanover, NH, USA.
Chris Bailey-KelloggDepartment of Computer Science, Dartmouth, Hanover, NH, USA.
Dartmouth College · USKorea Advanced Institute of Science and Technology · KRPrinceton University · US

Funding

Functional Deimmunization of Therapeutic ProteinsR01GM098977 · NIGMS · DARTMOUTH COLLEGE · PI BAILEY-KELLOGG, CHRIS, GRISWOLD, KARL E · 2011 to 2019
$3.4M
NIGMS NIH HHS R01 GM098977
6 · The paper itself

Abstract

Motivation: Disruption of protein-protein interactions can mitigate antibody recognition of therapeutic proteins, yield monomeric forms of oligomeric proteins, and elucidate signaling mechanisms, among other applications. While designing affinity-enhancing mutations remains generally quite challenging, both statistically and physically based computational methods can precisely identify affinity-reducing mutations. In order to leverage this ability to design variants of a target protein with disrupted interactions, we developed the DisruPPI protein design method (DISRUpting Protein-Protein Interactions) to optimize combinations of mutations simultaneously for both disruption and stability, so that incorporated disruptive mutations do not inadvertently affect the target protein adversely. Results: Two existing methods for predicting mutational effects on binding, FoldX and INT5, were demonstrated to be quite precise in selecting disruptive mutations from the SKEMPI and AB-Bind databases of experimentally determined changes in binding free energy. DisruPPI was implemented to use an INT5-based disruption score integrated with an AMBER-based stability assessment and was applied to disrupt protein interactions in a set of different targets representing diverse applications. In retrospective evaluation with three different case studies, comparison of DisruPPI-designed variants to published experimental data showed that DisruPPI was able to identify more diverse interaction-disrupting and stability-preserving variants more efficiently and effectively than previous approaches. In prospective application to an interaction between enhanced green fluorescent protein (EGFP) and a nanobody, DisruPPI was used to design five EGFP variants, all of which were shown to have significantly reduced nanobody binding while maintaining function and thermostability. This demonstrates that DisruPPI may be readily utilized for effective removal of known epitopes of therapeutically relevant proteins. Availability and implementation: DisruPPI is implemented in the EpiSweep package, freely available under an academic use license. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

MutationProtein BindingSoftwareAlgorithmsAntibodiesComputational BiologyGreen Fluorescent ProteinsProteinsAntibodiesenhanced green fluorescent proteinGreen Fluorescent ProteinsProteins

Identifiers

PMID29949961
PMCPMC6022686
OpenAlexW2808272353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.